Another trial has added to the movement towards shortening the duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). In the MASTER DAPT trial involving patients ...

The results of a large network meta-analysis throw additional support for a paradigm shift in how dual antiplatelet therapy (DAPT) should be maintained after PCI with drug-eluting stents, researchers ...

The saga of the Uniform Voidable Transactions Act (UVTA) has taken an interesting turn as, in March 2017, two additional state legislatures passed it: Michigan and Utah. These states now join ...

SAN FRANCISCO, CALIF.—Timing and discontinuation of dual anti-platelet therapy (DAPT) following stent implantation remains an open question, but evidence is growing that stopping the therapy early ...

WASHINGTON -- Beyond bleeding alone, a regimen of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) was associated with excess mortality, based on observational data ...

Please provide your email address to receive an email when new articles are posted on . In a subgroup analysis of MASTER-DAPT, regardless of whether patients had a history of MI, 1-month DAPT after ...

Please provide your email address to receive an email when new articles are posted on . For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved ...

In patients at high bleeding risk who had undergone percutaneous coronary intervention (PCI), 1 month of dual antiplatelet therapy (DAPT) was associated with a similar rate of major adverse cardiac or ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Since the ...

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug-eluting ...

To investigate the effect of DAPT (γ‐secretase inhibitor) on the growth of human tongue carcinoma cells and to determine the molecular mechanism to enable the potential application of DAPT to the ...